Clinical investigation of atypical adenomatous hyperplasia of the lung

Lung Cancer

Volumn 25, Issue 2, 1999, Pages 115-121

  Takigawa, Nagio ^a   Segawa, Yoshihiko ^a   Nakata, Masao ^a   Saeki, Hideyuki ^a   Mandai, Koichi ^a   Kishino, Daizo ^a   Shimono, Michihide ^a   Ida, Mikiko ^a   Eguchi, Kenji ^a  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

Author keywords

Adenocarcinoma; Adenoma; Hyperplasia; Lung neoplasmas; Precancerous conditions; Prognosis; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPERPLASIA; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; SMOKING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERPLASIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; SMOKING; SURVIVAL ANALYSIS;

EID: 0032815460     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(99)00055-0     Document Type: Article

References (19)

1. Clayton F. The spectrum and significance of bronchioloalveolar carcinomas. Pathol. Annu. 23:1988;361-394.
2. Hou M., Morishita Y., Iijima T., Mase K., Dai Y., Sekine S., Noguchi M. The implication of anthracosis in the development of pulmonary adenocarcinoma. Jpn. J. Cancer. Res. 89:1998;1251-1256.
3. Kabat G.C. Previous cancer and radiotherapy as risk factors for lung cancer in lifetime nonsmokers. Cancer. Causes. and. Control. 4:1993;489-495.
4. Kaneko M., Eguchi K., Ohmatsu H., Kakinuma R., Naruke T., Suemasu K., Moriyama N. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiology. Radiology. 201:1996;798-802.
5. Kawasaki M., Noguchi M., Morikawa A., Matsuno Y., Yamada T., Hirohashi S., Kondo H., Shimosato Y. Nuclear p53 accumulation by small-sized adenocarcinomas of the lung. Pathol. Int. 46:1996;486-490.
6. Kodama T., Biyajima S., Watanabe S., Shimosato Y. Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung. Am. J. Clin. Pathol. 85:1986;146-151.
7. Kwiatkowski D.J., Harpole D.H., Godleski J., Herndon II J.E., Shieh D.-B., Richards W., Blanco R., Xu H.-J., Strauss G.M., Sugarbaker D.J. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications. J. Clin. Oncol. 16:1998;2468-2477.
8. Martini N., Melamed M.R. Multiple primary lung cancers. J. Thorac. Cardiovasc. Surg. 70:1975;606-612.
9. Miller R.R. Bronchioloalveolar cell adenomas. Am. J. Surg. Pathol. 14:1990;904-912.
10. Nakayama H., Noguchi M., Tsuchiya R., Kodama T., Shimosato Y. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content. Mod. Pathol. 3:1990;314-320.
11. Naruke T., Tsuchiya R., Kondo H., Asamura H., Nakayama H. Implication of staging in lung cancer. Chest. 112:1997;242-248.
12. Noguchi M., Morikawa A., Kawasaki M., Matsuno Y., Yamada T., Hirohashi S., Kondo H., Shimosato Y. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer. 75:1995;2844-2852.
13. Noguchi M., Shimosato Y. The development and progression of adenocarcinoma of the lung. Hansen H.H. Lung Cancer. 1995;131-142 Kluwer Academic Publishers, Boston.
14. Osann K.E. Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer. Res. 51:1991;4893-4897.
15. Suzuki K., Nagai K., Yoshida J., Yokose T., Kodama T., Takahashi K., Nishimura M., Kawasaki H., Yokozaki M., Nishiwaki Y. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis. Cancer. 79:1997;1521-1526.
16. Suzuki K., Ogura T., Yokose T., Nagai K., Mukai K., Kodama T., Nishiwaki Y., Esumi H. Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia. Int. J. Cancer. (Pred. Oncol). 79:1998;384-389.
17. UICC. TNM classification of malignant tumors. New York: Wiley-Liss, 1997: 91-7.
18. World Health Organization. Histological typing of lung tumors. 2nd ed. Genova: World Health Organization, 1981.
19. Yokozaki M., Kodama T., Yokose T., Matsumoto T., Mukai K. Differentiation of atypical adenomatous hyperplasia of the lung by use of DNA ploidy and morphometric analysis. Mod. Pathol. 9:1996;1156-1164.